Last reviewed · How we verify

NCT07149025

OMT & Intractable Singultus

Completed NA Last updated 29 August 2025
What this trial tests

NA trial testing Osteopathic Manipulative Therapy in Hiccup in 5 participants. Completed in 28 February 2025.

Timeline
1 May 2023
Primary endpoint
11 February 2025
28 February 2025

Quick facts

Lead sponsorMichigan State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment5
Start date1 May 2023
Primary completion11 February 2025
Estimated completion28 February 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Michigan State University

Who can join

18 and older, any sex, with Hiccup. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study plans to use the effects osteopathic manipulative medicine (OMM) techniques to aid in treatment of patients with symptoms of, somatic dysfunction related to, and/or a diagnosis of Intractable Singultus. The aim of our study is to document any changes in associated symptoms of Intractable Singultus before and after osteopathic manipulative treatment (OMT).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Osteopathic Manipulative Therapy

Trials testing the same drug.

Other Michigan State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07149025.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing